Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
| Image |  |
|---|---|
| Description | scientific article published in 2019 |
| Author/s |
author: François Raffi Jean-Michel Molina Anne-Geneviève Marcelin |
| Publication date | September 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |